Peter Lamb
14Patents
6h-index
36Co-inventors
66Inventor score
Filing activity: Jul 24, 2001 → Nov 25, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7704995B2 | Protein kinase modulators and methods of use | Chemistry; Metallurgy | 60 | Expired |
| US8877776B2 | (L)-malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | Chemistry; Metallurgy | 47 | Active |
| US7999006B2 | Methods of using MEK inhibitors | Human Necessities | 45 | Active |
| US9809549B2 | Malate salt of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer | Chemistry; Metallurgy | 24 | Active |
| US8642584B2 | Method of using PI3K and MEK modulators | Chemistry; Metallurgy | 20 | Active |
| US6498155B1 | Methods of treating thrombocytopenia | Human Necessities | 12 | Expired |
| US11098015B2 | Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer | Chemistry; Metallurgy | 5 | Active |
| US8481001B2 | Combination therapies comprising quinoxaline inhibitors of P13K-alpha for use in the treatment of cancer | Human Necessities | 4 | Active |
| US11091440B2 | Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)- N′-(4-fluorophenyl)cyclopropane-1,1 -dicarboxamide, and crystalline forms thereof for the treatment of cancer | Chemistry; Metallurgy | 4 | Active |
| US11091439B2 | Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer | Chemistry; Metallurgy | 4 | Active |
| US8513266B2 | Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha | Human Necessities | 3 | Active |
| US11065240B2 | Drug combinations to treat multiple myeloma | Human Necessities | 2 | Active |
| US12275706B2 | Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US8802692B2 | Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.